Alpha 2.0
Login Register
» Articles » PMID: 3067055

Human C5a Anaphylatoxin: Gene Synthesis, Expression, and Recovery of Biologically Active Material from Escherichia Coli

Overview
Journal Methods Enzymol
Specialty Biochemistry
Date 1988 Jan 1
PMID 3067055
Citations 6
Authors
A E Franke
G C ANDREWS
C J Gerard
H J Showell
Affiliations
Soon will be listed here.
Citing Articles

Comparative analysis of different biofactories for the production of a major diabetes autoantigen.

Avesani L, Merlin M, Gecchele E, Capaldi S, Brozzetti A, Falorni A Transgenic Res. 2013; 23(2):281-91.

PMID: 24142387 PMC: 3951962. DOI: 10.1007/s11248-013-9749-9.

Expression and subcellular targeting of human complement factor C5a in Nicotiana species.

Nausch H, Mikschofsky H, Mischofsky H, Koslowski R, Meyer U, Broer I PLoS One. 2013; 7(12):e53023.

PMID: 23285250 PMC: 3532468. DOI: 10.1371/journal.pone.0053023.

Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.

Carney D, Hugli T Protein Sci. 1993; 2(9):1391-9.

PMID: 8401225 PMC: 2142461. DOI: 10.1002/pro.5560020904.

Specific inhibition of leukotriene B4 (LTB4)-induced neutrophil emigration by 20-hydroxy LTB4: implications for the regulation of inflammatory responses.

Pettipher E, Salter E, Breslow R, Raycroft L, Showell H Br J Pharmacol. 1993; 110(1):423-7.

PMID: 8220903 PMC: 2176035. DOI: 10.1111/j.1476-5381.1993.tb13827.x.

The pharmacophore of the human C5a anaphylatoxin.

Toth M, Huwyler L, Boyar W, Braunwalder A, Yarwood D, Hadala J Protein Sci. 1994; 3(8):1159-68.

PMID: 7987211 PMC: 2142918. DOI: 10.1002/pro.5560030802.